We're thrilled to share the exciting news of launching our inaugural affiliate in the UK! Our decision to expand into the UK is driven by multiple factors:

Over recent years, we've observed that the UK, despite Brexit, continues to be a highly appealing destination for medical research.
With world-renowned centers of medical innovation like University of Cambridge and University of Oxford, many of our clients are either based in the UK or have significant operations there.

At iliomad Health Data , our mission is to support our clients in the best possible locations, and the UK certainly provides an excellent setting for this.

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified

Home

Discover our latest articles

View All Blog Posts
February 28, 2024
Clinical Trials
Data Transfers
GDPR
DPIA

Importance of Data Mapping and Data Flow in Clinical Trials

Data mapping and data flow are crucial components in the management of data, especially in the context of clinical trials. These processes not only ensure compliance with data protection regulations but also enhance the integrity and security of data handling. Here's a breakdown of the key points from your text, specifically tailored to emphasize their significance in clinical trials.

January 17, 2024
Health Data Strategy

Opening of the Belgian Health Data Agency

On January 17, 2024, Belgium inaugurated its new Health Data Agency, a project approved a year earlier. The agency is designed to improve the accessibility and reusability of health data for secondary purposes. This enhancement of data availability will be executed in a manner that ensures both security and adherence to privacy regulations.

January 10, 2024
Health Data Strategy
Regulation

New Concerns For The Life Sciences Industry: Data Sovereignty and Data Hosting

The concept of data sovereignty is currently a hot topic in Europe. This relatively new idea originated from a series of events and geopolitical changes that began in the early 2000s.The issue of data control is emerging as a significant consideration, especially for companies strategizing future data management. This is especially relevant for life sciences companies with global operations, such as clinical trial sponsors managing international multi centric sites or AI health techs building models on international data sources.